Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 22.76 | 17.11 | 17.37 | 16.68 | 18.19 | 19.57 | 20.66 | 18.14 | 19.01 | 18.35 | 20.44 | 15.96 |
| Expenses | 20.28 | 14.88 | 14.71 | 15.07 | 16.88 | 17.59 | 18.53 | 15.78 | 16.88 | 15.83 | 18.40 | 14.77 |
| Operating Profit | 2.48 | 2.23 | 2.66 | 1.61 | 1.31 | 1.98 | 2.13 | 2.36 | 2.13 | 2.52 | 2.04 | 1.19 |
| OPM % | 10.90% | 13.03% | 15.31% | 9.65% | 7.20% | 10.12% | 10.31% | 13.01% | 11.20% | 13.73% | 9.98% | 7.46% |
| Other Income | 0.36 | 0.18 | 0.41 | 0.15 | 0.21 | 0.53 | 0.18 | 0.18 | 0.79 | -0.08 | 0.67 | 0.05 |
| Interest | 0.11 | 0.10 | 0.10 | 0.14 | 0.15 | 0.13 | 0.13 | 0.15 | 0.13 | 0.14 | 0.13 | 0.12 |
| Depreciation | 0.71 | 0.72 | 0.72 | 0.70 | 0.71 | 0.74 | 0.73 | 0.84 | 0.86 | 0.87 | 0.84 | 0.73 |
| Profit before tax | 2.02 | 1.59 | 2.25 | 0.92 | 0.66 | 1.64 | 1.45 | 1.55 | 1.93 | 1.43 | 1.74 | 0.39 |
| Tax % | 25.74% | 22.01% | 15.11% | 63.04% | 22.73% | 27.44% | 23.45% | 37.42% | 14.51% | 30.77% | 29.31% | 23.08% |
| Net Profit | 1.51 | 1.24 | 1.91 | 0.34 | 0.50 | 1.19 | 1.11 | 0.97 | 1.64 | 1.00 | 1.23 | 0.30 |
| EPS in Rs | 12.58 | 10.33 | 15.92 | 2.83 | 4.17 | 9.92 | 9.25 | 8.08 | 13.67 | 8.33 | 10.25 | 2.50 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 47.51 | 48.02 | 51.86 | 55.52 | 57.27 | 68.60 | 57.92 | 75.33 | 75.56 | 75.10 | 75.94 | 73.76 |
| Expenses | 41.04 | 41.30 | 47.44 | 49.79 | 51.10 | 59.01 | 50.92 | 66.73 | 66.53 | 68.08 | 66.91 | 65.88 |
| Operating Profit | 6.47 | 6.72 | 4.42 | 5.73 | 6.17 | 9.59 | 7.00 | 8.60 | 9.03 | 7.02 | 9.03 | 7.88 |
| OPM % | 13.62% | 13.99% | 8.52% | 10.32% | 10.77% | 13.98% | 12.09% | 11.42% | 11.95% | 9.35% | 11.89% | 10.68% |
| Other Income | 0.78 | 0.35 | 0.42 | 1.04 | 0.85 | 0.88 | 0.94 | 1.69 | 1.09 | 1.07 | 1.57 | 1.43 |
| Interest | 1.13 | 0.89 | 0.91 | 1.09 | 0.82 | 0.64 | 0.45 | 0.36 | 0.38 | 0.55 | 0.54 | 0.52 |
| Depreciation | 1.18 | 1.29 | 1.47 | 1.63 | 1.87 | 1.92 | 2.45 | 2.48 | 2.82 | 2.88 | 3.42 | 3.30 |
| Profit before tax | 4.94 | 4.89 | 2.46 | 4.05 | 4.33 | 7.91 | 5.04 | 7.45 | 6.92 | 4.66 | 6.64 | 5.49 |
| Tax % | 20.45% | 44.79% | 17.89% | 29.88% | 25.40% | 32.49% | 29.17% | 24.97% | 18.35% | 32.62% | 27.11% | |
| Net Profit | 3.92 | 2.70 | 2.01 | 2.84 | 3.23 | 5.34 | 3.56 | 5.58 | 5.65 | 3.14 | 4.83 | 4.17 |
| EPS in Rs | 32.67 | 22.50 | 16.75 | 23.67 | 26.92 | 44.50 | 29.67 | 46.50 | 47.08 | 26.17 | 40.25 | 34.75 |
| Dividend Payout % | 4.59% | 6.67% | 8.96% | 6.34% | 7.43% | 7.87% | 11.80% | 7.53% | 7.43% | 13.38% | 8.70% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 5% | 2% | 0% | -4% | ||
| Compounded Profit Growth | 3% | -1% | -3% | 17% | ||
| Stock Price CAGR | 5% | 2% | -1% | -4% | ||
| Return on Equity | 10% | 10% | 9% | 9% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 |
| Reserves | 16.94 | 20.65 | 23.27 | 25.15 | 27.77 | 30.78 | 35.69 | 39.11 | 44.43 | 49.64 | 52.37 | 56.88 |
| Borrowings | 8.88 | 7.37 | 7.44 | 9.76 | 9.56 | 7.19 | 7.10 | 5.99 | 5.83 | 5.55 | 5.45 | 8.43 |
| Other Liabilities | 15.50 | 17.30 | 19.23 | 15.59 | 18.76 | 17.13 | 21.38 | 16.14 | 12.70 | 11.56 | 15.21 | 12.57 |
| Total Liabilities | 42.52 | 46.52 | 51.14 | 51.70 | 57.29 | 56.30 | 65.37 | 62.44 | 64.16 | 67.95 | 74.23 | 79.08 |
| Fixed Assets | 19.48 | 18.57 | 18.39 | 20.78 | 24.39 | 23.66 | 26.36 | 25.82 | 24.26 | 24.03 | 24.64 | 23.88 |
| CWIP | 0.00 | 0.00 | 0.40 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 3.82 | 9.32 | 9.82 |
| Investments | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Other Assets | 23.03 | 27.94 | 32.34 | 30.67 | 32.89 | 32.63 | 39.00 | 36.61 | 39.76 | 40.09 | 40.26 | 45.37 |
| Total Assets | 42.52 | 46.52 | 51.14 | 51.70 | 57.29 | 56.30 | 65.37 | 62.44 | 64.16 | 67.95 | 74.23 | 79.08 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 3.49 | -0.10 | 1.92 | 4.97 | 5.22 | 5.49 | 8.21 | 5.19 | 2.45 | 8.23 | 4.86 | 4.24 |
| Cash from Investing Activity | -1.54 | -0.28 | -1.50 | -3.68 | -4.99 | -1.14 | -4.62 | -1.89 | -1.06 | -6.27 | -9.04 | -3.17 |
| Cash from Financing Activity | -2.12 | 0.47 | -0.25 | 1.07 | -2.54 | -3.33 | -1.24 | -1.23 | -1.01 | -1.04 | -1.85 | 2.91 |
| Net Cash Flow | -0.18 | 0.09 | 0.17 | 2.36 | -2.31 | 1.02 | 2.36 | 2.07 | 0.38 | 0.91 | -6.03 | 3.99 |
| Free Cash Flow | 1.95 | -0.38 | 0.42 | 1.29 | 0.23 | 4.35 | 3.59 | 3.30 | 1.39 | 1.96 | -4.18 | 1.07 |
| CFO/OP | 82% | 20% | 45% | 129% | 109% | 109% | 100% | 101% | 41% | 105% | 103% | 61% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 107.84 | 103.02 | 133.25 | 103.60 | 126.82 | 115.61 | 119.93 | 105.49 | 103.55 | 105.55 | 125.10 | 124.25 |
| Inventory Days | 93.92 | 115.50 | 137.30 | 119.80 | 93.95 | 78.44 | 60.42 | 104.59 | 82.82 | 75.88 | 92.47 | 89.34 |
| Days Payable | 159.39 | 136.34 | 186.56 | 138.65 | 161.71 | 120.01 | 137.94 | 105.98 | 76.58 | 63.30 | 126.07 | 78.42 |
| Cash Conversion Cycle | 42.37 | 82.19 | 83.99 | 84.75 | 59.05 | 74.04 | 42.41 | 104.10 | 109.79 | 118.13 | 91.50 | 135.16 |
| Working Capital Days | 9.22 | 46.86 | 102.84 | 90.58 | 88.75 | 88.78 | 75.02 | 79.02 | 87.02 | 91.64 | 106.68 | 130.16 |
| ROCE % | 21.35% | 21.59% | 18.91% | 9.82% | 13.77% | 13.26% | 20.56% | 11.83% | 16.04% | 13.41% | 8.94% | 12.06% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 73.66% | 73.66% | 73.66% | 73.66% | 73.66% | 73.66% | 73.66% | 73.66% | 73.66% | 73.66% | 73.66% | 73.66% |
| Public | 26.34% | 26.35% | 26.34% | 26.35% | 26.36% | 26.34% | 26.34% | 26.34% | 26.34% | 26.35% | 26.34% | 26.34% |
| No. of Shareholders | 1,149 | 1,161 | 1,214 | 1,259 | 1,345 | 1,411 | 1,397 | 1,384 | 1,365 | 1,321 | 1,316 | 1,328 |
Fundamentals
Market Cap₹ 91.2 Cr.
Current Price₹ 760
Stock P/E20.7
Book Value₹ 484
ROCE12.1 %
ROE9.19 %
Dividend Yield0.47 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-4%
Compounded Profit Growth (TTM)17%
Standalone figures.
Valuation
Market capRs 90 Cr
Enterprise valueRs 92 Cr
P/E (TTM)21.53x
Price to book1.55x
Price to sales1.22x
EV / EBITDA9.88x
EV / EBIT15.31x
EV / sales1.25x
Price to cash flow21.17x
Earnings yield4.65%
Dividend yield0.47%
P/E, 3-year average22.12x
P/B, 3-year average1.75x
P/E, 5-year average19.06x
P/B, 5-year average1.65x
Profitability
Operating margin (excl. other income)11.89%
Operating margin (incl. other income)13.96%
EBITDA margin12.62%
Pre-tax margin7.44%
Net profit margin5.65%
Net margin, latest quarter1.88%
ROE8.65%
ROCE11.44%
ROA6.30%
ROE, 3-year average8.79%
ROCE, 3-year average11.34%
ROA, 3-year average6.42%
ROE, 5-year average9.72%
ROCE, 5-year average12.43%
ROA, 5-year average6.73%
ROIC (approx.)7.26%
Tax rate27.11%
Other income / net worth2.70%
Growth
Sales growth (latest year)1.12%
Profit growth (latest year)53.82%
Sales CAGR, 3 years0.27%
Sales CAGR, 5 years2.05%
Profit CAGR, 3 years-4.70%
Profit CAGR, 5 years-1.99%
Sales growth QoQ-21.92%
Profit growth QoQ-75.61%
Sales growth YoY (latest quarter)-12.02%
Profit growth YoY (latest quarter)-69.07%
Per share
EPS (TTM)Rs 34.75
EPS (latest year)Rs 40.25
EPS (latest quarter)Rs 2.50
EPS, 3-year averageRs 37.83
EPS, 5-year averageRs 37.93
Book value per shareRs 484.00
Sales per shareRs 614.67
Cash flow per shareRs 35.33
Free cash flow per shareRs 8.92
Dividend per share (latest year)Rs 3.50
Dividend per share, 3-year averageRs 3.50
Dividend per share, 5-year averageRs 3.50
Dividends
Dividend payout8.70%
Dividend payout, 3-year average9.84%
Dividend payout, 5-year average9.77%
Efficiency
Asset turnover0.96x
Fixed asset turnover3.18x
Inventory turnover4.65x
Inventory days78 days
Debtor days124 days
Debtors turnover2.94x
Creditor days78 days
Cash conversion cycle135 days
Working capital days130 days
Leverage
Total debtRs 8 Cr
Cash and bankRs 6 Cr
Net debtRs 2 Cr
Debt to equity0.15x
Net debt / EBITDA0.24x
Interest coverage11.56x
Owners' fund to total sources73.44%
Debt to assets10.66%
Cash flow
Cash from Operating Activity (latest year)Rs 4 Cr
Cash from Investing Activity (latest year)Rs -3 Cr
Cash from Financing Activity (latest year)Rs 3 Cr
Net Cash Flow (latest year)Rs 4 Cr
Free cash flow (latest year)Rs 1 Cr
FCFE (approx.: FCF + change in debt)Rs 4 Cr
Cash from ops / profit, 5 years1.10x
Sales to cash flow17.91x
Statement figures
Net sales (TTM)Rs 74 Cr
Net sales (latest year)Rs 76 Cr
Sales (latest quarter)Rs 16 Cr
Operating profit excl. other income (latest year)Rs 9 Cr
Operating profit (latest quarter)Rs 1 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs 9 Cr
PBDT (TTM)Rs 9 Cr
Profit before tax (TTM)Rs 5 Cr
Tax (latest year)Rs 2 Cr
Net profit (TTM)Rs 4 Cr
Net profit (latest year)Rs 5 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 3 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 33 Cr
Total expenditure (latest year)Rs 67 Cr
Total income (latest year)Rs 78 Cr
Share capitalRs 1 Cr
ReservesRs 57 Cr
Shareholders' fundsRs 58 Cr
Total assetsRs 79 Cr
Net blockRs 24 Cr
Capital work in progressRs 10 Cr
InvestmentsRs 0 Cr
ReceivablesRs 26 Cr
InventoryRs 7 Cr
Other liabilitiesRs 13 Cr
Shares outstanding (crore)0.12
Ownership
Promoter holding73.66% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 21.5 is at the 70th percentile of its own 9.4-year range
(median 19.1, low 9.3, high 32.9).
P/B 1.55 is at the 19th percentile (median 1.92).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 538964 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -8.2% | -2.8% | -5.4 pts |
| 1 month | -4.2% | -6.8% | +2.6 pts |
| 3 months | -0.3% | -7.6% | +7.3 pts |
| 3 years | -6.3% | +14.2% | -20.4 pts |
| 5 years | +7.0% | +27.9% | -20.9 pts |
Red flags
F-score 5 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹16 Cr -12.0% vs Jun 2025.
Net profit ₹0 Cr -69.1%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Mercury Laboratories Ltd?
Mercury Laboratories Ltd (538964) has a market capitalisation of Rs 91.2 Cr. at the 2026-10-01 close.
What is the P/E ratio of Mercury Laboratories Ltd?
Mercury Laboratories Ltd trades at a P/E of 20.7 on trailing twelve-month profit, at the 2026-10-01 close.
What were Mercury Laboratories Ltd's latest quarterly results?
In the Jun 2026 quarter, Mercury Laboratories Ltd sales was Rs 16 Cr (-12.0% vs Jun 2025) and net profit was Rs 0 Cr.